Logo image of ARDX

ARDELYX INC (ARDX) Stock Analyst Ratings

NASDAQ:ARDX - Nasdaq - US0396971071 - Common Stock - Currency: USD

5.13  +0.07 (+1.38%)

After market: 5.12 -0.01 (-0.19%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ARDX. The Buy consensus is the weighted average rating of the current analysts ratings.

ARDX was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ARDX.
In the previous month the buy percentage consensus was at a similar level.
ARDX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
ARDX Historical Analyst RatingsARDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15
ARDX Current Analyst RatingARDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-02-21 Raymond James Reiterate Strong Buy -> Strong Buy
2025-02-21 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-01-27 Piper Sandler Maintains Neutral -> Neutral
2025-01-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-01-02 Jefferies Maintains Buy -> Buy
2024-11-11 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-11-04 Citigroup Maintains Buy -> Buy
2024-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Wedbush Reiterate Outperform -> Outperform
2024-08-02 Citigroup Maintains Buy -> Buy
2024-07-18 Wedbush Reiterate Outperform -> Outperform
2024-07-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-03 Citigroup Maintains Buy -> Buy
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-05-24 Wedbush Reiterate Outperform -> Outperform
2024-05-24 Piper Sandler Maintains Overweight -> Overweight
2024-05-03 Wedbush Maintains Outperform -> Outperform
2024-05-03 Citigroup Maintains Buy -> Buy
2024-04-17 Wedbush Maintains Outperform -> Outperform
2024-04-05 Leerink Partners Initiate Outperform
2024-02-23 Wedbush Reiterate Outperform -> Outperform
2024-02-23 Piper Sandler Maintains Overweight -> Overweight
2024-01-12 Wedbush Maintains Outperform -> Outperform
2024-01-10 Citigroup Maintains Buy -> Buy
2024-01-09 Raymond James Maintains Strong Buy -> Strong Buy
2023-12-18 Raymond James Initiate Strong Buy
2023-12-01 Wedbush Reiterate Outperform -> Outperform
2023-11-01 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-13 Wedbush Reiterate Outperform -> Outperform